Sarah Kathryn Rouan Viking Therapeutics, Inc. (VKTX) insider trading activity

Sarah Kathryn Rouan is of Viking Therapeutics, Inc.. Currently has a direct ownership of 4,390 shares of VKTX, which is worth approximately $174,722. The most recent transaction as insider was on Jan 02, 2026, when has been sold 3,150 shares (Common stock, par value $0.00001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.39K

254.03% 3M change

Infinity% 12M change

Total Value Held $174,722

Sarah Kathryn Rouan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	-	3,150 Added 41.78%	4,390 Common stock, par valu...
Mar 31 2025	BUY Open market or private purchase	$29,946 $24.15 p/Share	1,240 Added 50.0%	1,240 Common stock, par valu...
Oct 25 2024	SELL Open market or private sale	$889,790 $80.89 p/Share	11,000 Reduced 100.0%	0 Common stock, par valu...
Oct 25 2024	BUY Exercise of conversion of derivative security	$53,680 $4.88 p/Share	11,000 Added 50.0%	11,000 Common stock, par valu...
Feb 08 2024	SELL Open market or private sale	$701,250 $28.05 p/Share	25,000 Reduced 100.0%	0 Common stock, par valu...
Feb 08 2024	BUY Exercise of conversion of derivative security	$208,000 $8.32 p/Share	25,000 Added 50.0%	25,000 Common stock, par valu...
Jan 19 2024	SELL Open market or private sale	$691,500 $23.05 p/Share	30,000 Reduced 100.0%	0 Common stock, par valu...

Jan 19 2024	BUY Exercise of conversion of derivative security	$249,600 $8.32 p/Share	30,000 Added 50.0%	30,000 Common stock, par valu...

Also insider at

NAVB

NAVIDEA BIOPHARMACEUTICALS, INC. Healthcare

Director

SKR